Cipla
Shivanjali Batra currently serves as Deputy Manager and COE-Lead at Cipla since August 2023. Previously, Shivanjali gained valuable experience at SUN PHARMA from August 2018 to August 2023, progressing from Graduate Engineer Trainee to Senior Executive and ultimately Manager. Shivanjali holds a Bachelor of Technology in Chemical Engineering from Dr. B. R. Ambedkar National Institute of Technology, Jalandhar, where studies were completed from 2014 to 2018. Prior education includes a Higher Secondary degree in Non-Medical and a Secondary School degree in Science from Swami Sant Dass Public School.
This person is not in the org chart
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.